LY03003

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY03003, covering 2015-10-21 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD [Phase 3]